XNET XNET
Company Profile ↓Company Overview
XNET (XNET) is a publicly traded company listed on with a market capitalization of $2.00B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Generates a return on equity of 76.3%, reflecting efficient use of shareholder capital.
Return on capital employed stands at 73.6%.
Net profit has compounded at 265.5% per year over the last five years.
Revenue has grown at a 10.5% CAGR over the past five years.
Trades at an undemanding P/E of 0.3.
Carries low leverage with a debt-to-equity ratio of 0.06.
Recent Developments
- Dec 2025 Revenue of $460.43M (+42.5% YoY); net profit $1.05B.
- Trailing 12 Months Year-on-year growth — revenue +42.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 10.5%, profit CAGR 265.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 10.47% |
| 1 Year: | 42.49% |
Compounded Profit Growth
| 5 Years: | 265.53% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | +21.09% |
| 6 Months: | -18.72% |
| 3 Months: | -12.17% |
| 1 Month: | -8.56% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)45.44 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 76.3%.
- Healthy ROCE of 73.6%.
- Compounding revenue at 10.5% over 5 years.
- Profit CAGR of 265.5% over 5 years.
- Generates positive free cash flow.
CONS
- Trading 50.5% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 63.73M | 103.55M | 125.93M | 142.50M | 98.11M |
| Cost of Revenue | 24.15M | 52.32M | 65.39M | 80.83M | 40.41M |
| Gross Profit | 39.58M | 51.23M | 60.54M | 61.67M | 57.70M |
| Operating Expenses | 40.54M | 50.11M | 57.82M | 55.83M | 53.40M |
| Operating Income | -966.00K | 1.11M | 2.73M | 5.84M | 4.30M |
| EBITDA | 1.21M | 723.92M | 551.09M | -227.41M | -190.01M |
| Interest Expense | 220.00K | 328.00K | 574.00K | 576.00K | 529.00K |
| Pretax Income | 990.00K | 723.59M | 550.52M | -227.98M | -190.54M |
| Tax Provision | 1.15M | -3.81M | 469.00K | 914.00K | 1.85M |
| Net Income | -800.00K | 727.59M | 550.25M | -228.78M | -174.64M |
| Diluted EPS | -0.01 | 11.48 | 8.60 | -3.64 | -2.77 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 341.50M | 363.72M | 323.14M | 460.43M |
| Cost of Revenue | - | 200.05M | 200.65M | 155.57M | 242.89M |
| Gross Profit | - | 141.44M | 163.07M | 167.57M | 217.54M |
| Operating Expenses | - | 127.78M | 161.49M | 161.47M | 209.75M |
| Operating Income | - | 13.66M | 1.59M | 6.10M | 7.79M |
| EBITDA | - | 29.32M | 25.99M | 5.30M | 1.06B |
| Interest Expense | - | 93.00K | 1.51M | 728.00K | 1.70M |
| Pretax Income | - | 25.41M | 18.40M | -2.36M | 1.05B |
| Tax Provision | - | 4.07M | 4.13M | -3.02M | -1.28M |
| Net Income | - | 21.46M | 14.22M | 1.22M | 1.05B |
| Diluted EPS | - | 0.32 | 0.22 | 0.02 | 16.56 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 463.32M | 468.69M | 473.90M | 1.63B |
| Current Assets | - | 332.18M | 327.38M | 363.03M | 399.67M |
| Cash & Equivalents | - | 177.15M | 170.80M | 177.33M | 157.02M |
| Inventory | - | 457.00K | 2.22M | 1.25M | 403.00K |
| Receivables | - | 29.76M | 31.21M | 32.66M | 68.41M |
| Total Liabilities | - | 154.90M | 145.21M | 156.12M | 259.41M |
| Current Liabilities | - | 128.29M | 128.09M | 126.74M | 208.45M |
| Long Term Debt | - | 24.75M | 15.54M | 27.13M | 38.41M |
| Total Debt | - | 32.36M | 22.95M | 29.63M | 77.36M |
| Total Equity | - | 309.89M | 324.86M | 318.06M | 1.37B |
| Shares Outstanding | - | 375.00M | 375.00M | 375.00M | 375.00M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 51.11M | 25.72M | 30.98M | 32.48M |
| Investing Cash Flow | - | 11.76M | -23.90M | -21.91M | -99.10M |
| Financing Cash Flow | - | 6.64M | -13.52M | -925.00K | 45.48M |
| Capital Expenditure | - | -14.98M | -4.49M | -8.35M | -5.80M |
| Free Cash Flow | - | 36.13M | 21.23M | 22.63M | 26.68M |
| Net Change in Cash | - | 69.51M | -11.71M | 8.14M | -21.14M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 41.4% | 44.8% | 51.9% | 47.2% |
| Operating Margin % | - | 4.0% | 0.4% | 1.9% | 1.7% |
| Net Margin % | - | 6.3% | 3.9% | 0.4% | 227.7% |
| ROE % | - | 6.9% | 4.4% | 0.4% | 76.3% |
| ROCE % | - | 4.1% | 0.5% | 1.8% | 0.5% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XNET
XNET — Frequently Asked Questions
What is the current share price of XNET?
As of 2026-08-02 19:16 PDT, XNET trades at $5.34 on NASDAQ/NYSE. Its 52-week range is $4.38 to $10.78.
What is the market capitalisation of XNET?
XNET has a market capitalisation of $2.00B on NASDAQ/NYSE.
What is the P/E ratio of XNET?
XNET trades at a trailing price-to-earnings (P/E) ratio of 0.32. Its price-to-book (P/B) ratio is 1.46.
What is the return on equity (ROE) of XNET?
XNET has a return on equity (ROE) of 76.32%. Its return on capital employed (ROCE) is 73.62%.
Is XNET a good stock to buy?
This page provides a data-driven analysis of XNET, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.